DCGVX | RMEBX | DCGVX / RMEBX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 24 years | 10 years | - |
Gain YTD | 5.997 | 9.777 | 61% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 250 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.88B | 102B | 7% |
Annual Yield % from dividends | 0.26 | 1.54 | 17% |
Returns for 1 year | 6.94 | 10.96 | 63% |
Returns for 3 years | 7.20 | 11.91 | 60% |
Returns for 5 years | 10.83 | 36.81 | 29% |
Returns for 10 years | 1.72 | 57.99 | 3% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RYCFX | 40.98 | 0.46 | +1.14% |
Rydex Biotechnology C | |||
IVOYX | 18.33 | 0.20 | +1.10% |
Delaware Ivy Mid Cap Income Opps Y | |||
MAGCX | 26.53 | 0.21 | +0.80% |
BlackRock Advantage Global Institutional | |||
CIBCX | 69.01 | 0.49 | +0.72% |
American Funds Capital Income Bldr C | |||
OSMNX | 33.74 | 0.10 | +0.30% |
Invesco International Small-Mid Com R |